Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoidsMohamed Elbadawy, Kazuaki Sasaki|Frontiers in Pharmacology|2023Cited by 25